Evidence for D2 Receptor Mediation of Amphetamine-induced Normalization of Locomotion and Dopamine Transporter Function in Hypoinsulinemic Rats.
From: Department of Pharmacology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229-3900, USA.
Journal of neurochemistry
- Publish Date: Apr 2007
- ISSN: 0022-3042
- Volume: 101
- Issue: 1
- Pages: 151-9
- Medium: Print
- Language: English
- Citation (JAMA): Sevak Rajkumar J, Owens W Anthony, Koek Wouter, et al. Evidence for D2 Receptor Mediation of Amphetamine-induced Normalization of Locomotion and Dopamine Transporter Function in Hypoinsulinemic Rats.. J. Neurochem. Apr 2007;101:151-9
Abstract
Dopamine (DA) D2 receptors regulate DA transporter (DAT) activity, and mediate some behavioral effects of amphetamine. DA clearance and amphetamine-stimulated locomotion are reduced in hypoinsulinemic [streptozotocin (STZ)-treated] rats, and these deficits are normalized by repeated treatment with amphetamine. Here, a role for D2 receptors in mediating amphetamine-induced normalization of these parameters was investigated. One week after a saline or STZ injection (50 mg/kg), rats were treated with amphetamine (1.78 mg/kg), raclopride (0.056 mg/kg), saline, or combinations thereof, every-other-day for 8 days with locomotor activity measured following each treatment. Conditioned place preference (CPP) for amphetamine and in vivo chronoamperometry to measure DA clearance were carried out on days 17 and 18, respectively, after STZ or saline. Baseline locomotion and DA clearance were significantly reduced in STZ-treated rats compared with control rats. In STZ-treated rats, amphetamine treatment normalized DA clearance, and restored the locomotor-stimulating effects of amphetamine. Raclopride prevented normalization of these parameters. Amphetamine produced CPP in both STZ-treated and control rats; raclopride significantly attenuated amphetamine-induced CPP in control and not in STZ-treated rats. These results support a role for D2 receptors in regulating DA transporter activity, and further demonstrate that D2 receptors contribute to changes in sensitivity to amphetamine in hypoinsulinemic rats.
Mesh Headings (Keywords): Amphetamine, Animals, Blood Glucose, Brain, Brain Chemistry, Diabetes Mellitus, Experimental, Dopamine, Dopamine Agents, Dopamine Antagonists, Dopamine Plasma Membrane Transport Proteins, Drug Resistance, Hyperkinesis, Insulin, Male, Raclopride, Rats, Receptors, Dopamine D2
Check for Full Text / PubMed Unique Identifier (PMID): 17217413
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.